ALPS Medical Breakthroughs ETF Rating $64.90 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.77Holdings in SBIO have an aggregate rating of Moderate Buy based on 321 analyst ratings issued in the past year covering 25 companies (55.9% of the portfolio).SBIO Aggregate Price Target$64.90High Prediction$64.90Average Prediction$64.90Low Prediction$64.90Holdings in SBIO have an aggregate price target of $64.90 and a range of $64.90 to $64.90 covering 25 companies (55.9% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.45%APGEApogee Therapeutics$132.911.1321 of 5 stars2.24$121.25 -8.8%21Insider Trade3.45%CGONCG Oncology$70.363.4049 of 5 stars2.71$81.73 16.2%14News Coverage3.13%XENEXenon Pharmaceuticals$60.963.9971 of 5 stars3.00$77.20 26.6%17News Coverage2.97%TVTXTravere Therapeutics$56.900.0%2.0881 of 5 stars2.69$52.08 -8.5%13News CoveragePositive News2.97%ORKAOruka Therapeutics$85.213.16 of 5 stars2.82$134.30 57.6%11Analyst DowngradeHigh Trading Volume2.88%MANEVeradermics$129.86+0.1%0.7491 of 5 stars2.63$114.20 -12.1%82.83%DNTHDianthus Therapeutics$94.342.28 of 5 stars2.93$117.82 24.9%14Gap Down2.67%DFTXDefinium Therapeutics$44.192.0794 of 5 stars3.00$46.92 6.2%17Analyst Forecast2.42%EWTXEdgewise Therapeutics$39.563.3539 of 5 stars2.78$47.30 19.6%9Insider Trade2.35%ACADACADIA Pharmaceuticals$25.974.6673 of 5 stars2.65$32.59 25.5%17Analyst ForecastGap Down2.20%DNLIDenali Therapeutics$25.832.5662 of 5 stars2.81$34.25 32.6%162.20%RLAYRelay Therapeutics$18.652.7865 of 5 stars3.00$23.30 24.9%11News CoverageInsider TradeGap Down2.11%NAMSNewAmsterdam Pharma$34.832.217 of 5 stars2.83$49.00 40.7%12Analyst ForecastGap Up2.10%CRNXCrinetics Pharmaceuticals$42.233.6074 of 5 stars2.91$73.78 74.7%11Positive NewsAnalyst Forecast1.92%GPCRStructure Therapeutics$53.451.7972 of 5 stars2.89$110.55 106.8%18Positive News1.88%DYNDyne Therapeutics$23.072.7891 of 5 stars2.86$34.17 48.1%14Insider TradeGap Down1.75%IDYAIDEAYA Biosciences$37.653.1424 of 5 stars2.82$50.69 34.6%17Gap Down1.65%VERAVera Therapeutics$41.203.1637 of 5 stars2.75$78.00 89.3%12Gap UpHigh Trading Volume1.55%IRONDisc Medicine$76.262.3392 of 5 stars2.73$104.44 37.0%11Insider Trade1.50%CLDXCelldex Therapeutics$38.372.4311 of 5 stars2.82$49.30 28.5%11Gap Down1.47%KLRAKailera Therapeutics$21.993.6356 of 5 stars3.00$42.75 94.4%7News CoverageGap Down1.47%TARSTarsus Pharmaceuticals$65.442.89 of 5 stars2.78$90.67 38.5%9News CoverageHigh Trading Volume1.37%BCRXBioCryst Pharmaceuticals$9.842.8329 of 5 stars2.73$21.67 120.2%11Analyst ForecastAnalyst Revision1.35%MBXMBX Biosciences$57.800.8229 of 5 stars2.77$60.22 4.2%13News CoverageGap Down1.28%VCELVericel$46.982.2328 of 5 stars2.43$52.50 11.7%7News CoverageInsider TradeGap Down This page (NYSEARCA:SBIO) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBIO Stock Alerts